Parapneumonic pleural effusion (ppnpe) and microbiological isolation. Study routine or selective? Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Could microsatellite analysis of pleural fluid increase sensitivity of pleural fluid cytology? Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007
Evaluating the presence of SARS-CoV-2 RNA in the pleural fluid of patients undergoing pleural procedures without symptoms of COVID-19 Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease Year: 2021
Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Cytological effects of prolonged storage of fresh pleural fluid samples Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Does the pleural fluids parameters predict closed pleural needle biopsy? Source: Annual Congress 2003 - Pleural effusion Year: 2003
Pleural fluid AFB culture predicts the development of residual pleural thickening in tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110 Year: 2002
Diagnostic yield of pleural fluid cytology in malignant effusions – Is timing of collection important? Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006
Can pleural biopsy histology in combination with pleural fluid adenosine deaminase be used for diagnoses of pleural TB? Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy? Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006
The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010
Does pleural fluid sample size matter in the cytopathological assessment of unilateral pleural effusion? Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Cytology positive pleural aspirations: sufficient to guide treatment? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019
In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment? Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Does blind percutaneous pleural biopsy have a role in the investigation of pleural effusion? A pooled analysis Source: Annual Congress 2009 - Pleural diseases Year: 2009
Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003